{'fraction_non_alphanumeric': 0.02826086956521739, 'fraction_numerical': 0.008695652173913044, 'mean_word_length': 5.681159420289855, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Encephalitogenic peptide and platelet aggregation in multiple sclerosis

Platelet aggregation (PA) stimulated by encephalitogenic peptide (EP) and PA induced by ADP were measured in 83 multiple sclerosis (MS) patients and 70 control subjects with other neurological diseases (OND). EP‐stimulated PA was significantly increased in MS patients as compared with the controls. There was no significant difference in ADP‐induced PA between patients with MS and OND.